Apogee Therapeutics, Inc. (APGE)
↓ Download CSV| Metric (FY) | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Income | -$285.60M | -$216.87M | -$93.00M | — |
| Net Income | -$255.84M | -$182.15M | -$83.98M | — |
| EPS (Diluted) | $-4.22 | $-3.30 | $-3.36 | — |
| Total Assets | $937.13M | $753.95M | $401.40M | $152.06M |
| Total Liabilities | $33.25M | $37.16M | $21.49M | $9.98M |
| Cash & Equivalents | $131.55M | $141.79M | $118.32M | $151.89M |
| Operating Cash Flow | -$227.45M | -$171.17M | -$74.76M | — |
| Capital Expenditures | $5.15M | $1.15M | $167.0K | — |
| Shares Outstanding | 68.40M | 58.06M | 48.34M | 0 |